Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06637_nanopub.RA54ZVSoDKWhx3eWDaxj5l4wrYfutpxmIJGmjrhlstZwM#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB06637 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06637 label "Dalfampridine [drugbank:DB06637]" assertion.
- drugbank:DB06637 seeAlso DB06637 assertion.
- drugbank:DB06637 seeAlso ampyra.html assertion.
- drugbank:DB06637 seeAlso ampyra-drug.htm assertion.
- drugbank:DB06637 identifier "drugbank:DB06637" assertion.
- drugbank:DB06637 description "Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010." assertion.
- drugbank:DB06637 title "Dalfampridine" assertion.
- drugbank:DB06637 bio2rdf_vocabulary:identifier "DB06637" assertion.
- drugbank:DB06637 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06637 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06637" assertion.
- drugbank:DB06637 bio2rdf_vocabulary:x-identifiers.org DB06637 assertion.
- drugbank:DB06637 drugbank_vocabulary:drugbank-id "DB06637" assertion.
- drugbank:DB06637 drugbank_vocabulary:x-cas cas:504-24-5 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-ahfs ahfs:92:92 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-atc atc:N07XX07 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-chebi chebi:34385 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-kegg kegg:C13728 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-kegg kegg:D04127 assertion.
- drugbank:DB06637 drugbank_vocabulary:x-wikipedia wikipedia:4-Aminopyridine assertion.
- drugbank:DB06637 drugbank_vocabulary:x-ndc ndc:10144-427-60 assertion.